{"ticker": {"uuid": "564122db-b46e-4572-b8ab-d43a67c39f83", "symbol": "TOI", "name": "Oncology Institute Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Care Facilities"}, "articles": [{"title": "TOI (NASDAQ: TOI) plans sale of 23,452 shares worth $146,575.00", "summary": "The Oncology Institute, Inc. (NASDAQ: TOI) has filed a Form 144 notice indicating a planned sale of 23,452 shares of common stock, valued at $146,575.00, through Morgan Stanley Smith Barney LLC Executive Financial Services. These shares were acquired on July 14, 2026, via an exer", "url": "https://www.stocktitan.net/sec-filings/TOI/144-oncology-institute-inc-sec-filing-6906e01b8853.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:41:59", "published_display": "14 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 The Oncology Institute For: 14 July By Investing.com", "summary": "This article announces a Form 144 filing for The Oncology Institute, specifically for July 14th. The content is very brief, mainly serving as a headline for a financial market filing, with no further details provided within the article itself. It includes related stock market dat", "url": "https://ca.investing.com/news/stock-market-news/form-144-the-oncology-institute-for-14-july-93CH-4733933", "source_name": "Investing.com Canada", "published_at": "2026-07-14T20:41:59", "published_display": "14 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Jorey Chernett Acquires Additional Shares of The Oncology Institute Inc (TOI)", "summary": "Jorey Chernett, a 10% Owner of The Oncology Institute Inc (TOI), purchased an additional 15,000 shares on July 10, 2026, increasing his total holdings to 10,630,858 shares. This purchase is part of a broader trend of insider buying for TOI, with Chernett having acquired 759,914 s", "url": "https://www.gurufocus.com/news/8955984/insider-buying-jorey-chernett-acquires-additional-shares-of-the-oncology-institute-inc-toi", "source_name": "GuruFocus", "published_at": "2026-07-13T18:40:52", "published_display": "13 Jul 2026 18:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) major holder buys 15,000 shares in open market", "summary": "Jorey Chernett, a major shareholder (over 10% owner) of Oncology Institute, Inc. (TOI), purchased 15,000 shares of common stock on July 10, 2026, for a weighted average price of $5.85 per share. This open-market transaction, detailed in a Form 4 filing, involved multiple trades w", "url": "https://www.stocktitan.net/sec-filings/TOI/form-4-oncology-institute-inc-insider-trading-activity-4a8cb138f084.html", "source_name": "Stock Titan", "published_at": "2026-07-13T15:39:35", "published_display": "13 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Oncology Institute Inc For: 13 July By Investing.com", "summary": "This article from Investing.com announces the filing of a Form 4 for Oncology Institute Inc on July 13. It includes general market data and related news articles, but provides no specific details about the Form 4 itself.", "url": "https://ca.investing.com/news/stock-market-news/form-4-oncology-institute-inc-for-13-july-93CH-4731571", "source_name": "Investing.com Canada", "published_at": "2026-07-13T15:39:35", "published_display": "13 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute (TOI) Proxy filing Summary", "summary": "The Oncology Institute (TOI) has released a proxy filing summary detailing its upcoming annual meeting scheduled for June 17, 2026. Key items include the election of eight directors, the ratification of BDO as the independent public accounting firm for 2026, and advisory votes on", "url": "https://quartr.com/events/the-oncology-institute-toi-proxy-filing_onCTCXdr", "source_name": "Quartr", "published_at": "2026-07-10T11:10:04", "published_display": "10 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TOIIW SEC Filings - The Oncology Institute Inc 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for SEC filings related to The Oncology Institute Inc. (TOIIW), including 10-K, 10-Q, 8-K, and insider trading forms. Recent updates detail insider transactions by director Gabriel Ling, his resignation from the board, and a significant", "url": "https://www.stocktitan.net/sec-filings/TOIIW/page-5.html", "source_name": "Stock Titan", "published_at": "2026-07-10T09:09:37", "published_display": "10 Jul 2026 09:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) Short Interest & Short Float | Updated Jul 2026 $TOI", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE1ISmJtZlMxVkRNRm9XSWFsNDRIUGZncEhEVTNFdlIxTkphb3JPNl9laUVEU0ZJLWRRTVotMkRXZnJtb2k1a2tJQmdwT3dsVURaRHlQUEdISEZKTkdCTnEwTGp4MlBGTTFEQ3Q4Sg?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute Price Target Raised to $9.00/Share From $8.00 by BTIG", "summary": "BTIG has increased its price target for The Oncology Institute to $9.00 per share, up from the previous $8.00. This adjustment by BTIG analysts suggests a more optimistic outlook for the company's stock performance. The Oncology Institute is traded on the NASDAQ under the ticker ", "url": "https://www.moomoo.com/news/post/72730789/oncology-institute-price-target-raised-to-9-00-share-from", "source_name": "Moomoo", "published_at": "2026-07-10T00:10:04", "published_display": "10 Jul 2026 00:10", "sentiment": "positive", "sentiment_pct": 69, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains The Oncology Institute(TOI.US) With Buy Rating, Raises Target Price to $9", "summary": "BTIG has reiterated its Buy rating on The Oncology Institute (TOI.US) and increased its target price to $9. This indicates a positive outlook from the analyst firm regarding the company's future stock performance.", "url": "https://www.moomoo.com/news/post/72730109/btig-maintains-the-oncology-institute-toius-with-buy-rating-raises", "source_name": "Moomoo", "published_at": "2026-07-09T23:41:59", "published_display": "09 Jul 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG raises Oncology Institute stock price target to $9 on debt refinancing", "summary": "BTIG has increased its price target for The Oncology Institute (NASDAQ:TOI) to $9.00 from $8.00, maintaining a Buy rating after the company announced it refinanced its $86 million senior secured convertible note. The refinancing involved a new $75 million term loan from OrbiMed a", "url": "https://www.investing.com/news/analyst-ratings/btig-raises-oncology-institute-stock-price-target-to-9-on-debt-refinancing-93CH-4784657", "source_name": "Investing.com", "published_at": "2026-07-09T22:10:04", "published_display": "09 Jul 2026 22:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) director receives 17,185-share fully vested RSU grant", "summary": "Oncology Institute (TOI) director Kimberly Jo Tzoumakas received a fully vested Restricted Stock Unit (RSU) grant of 17,185 shares of common stock on July 7, 2026, as reported in a Form 4 SEC filing. The grant was recorded at a price of $0.00 per share and is considered compensat", "url": "https://www.stocktitan.net/sec-filings/TOI/form-4-oncology-institute-inc-insider-trading-activity-2c1093db91d0.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:59:19", "published_display": "09 Jul 2026 20:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) director receives 25,833 fully vested RSU shares", "summary": "Oncology Institute (TOI) director Mark Stolper reported receiving 25,833 fully vested Restricted Stock Units (RSU) shares of common stock on July 7, 2026, as an equity compensation grant. This transaction, classified as a non-cash award at $0.00 per share, increases Stolper's dir", "url": "https://www.stocktitan.net/sec-filings/TOI/form-4-oncology-institute-inc-insider-trading-activity-8738f43a0a78.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:59:18", "published_display": "09 Jul 2026 20:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Initiates The Oncology Institute(TOI.US) With Buy Rating, Announces Target Price $10", "summary": "Lake Street has initiated coverage on The Oncology Institute (TOI.US) with a \"Buy\" rating and set a price target of $10. This signals a positive outlook from the analyst firm regarding the company's future performance.", "url": "https://www.moomoo.com/news/post/72524018/lake-street-initiates-the-oncology-institute-toius-with-buy-rating", "source_name": "Moomoo", "published_at": "2026-07-07T22:10:05", "published_display": "07 Jul 2026 22:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (NASDAQ: TOI) adds $75M OrbiMed loan in major refi", "summary": "The Oncology Institute (NASDAQ: TOI) has completed a major refinancing deal, securing a new $75 million term loan from OrbiMed Opportunities. This new loan, maturing in 2031, was used along with $11 million in cash to repay their existing $86 million 4% senior secured convertible", "url": "https://www.stocktitan.net/sec-filings/TOI/8-k-oncology-institute-inc-reports-material-event-61d126af9287.html", "source_name": "Stock Titan", "published_at": "2026-07-07T21:01:14", "published_display": "07 Jul 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "This article provides the enterprise value to forward revenue for The Oncology Institute, Inc., traded on NASDAQ under the ticker TOI. It is presented in the context of financial data available on TradingView, covering market information and financial performance indicators for t", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T14:41:14", "published_display": "07 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/oncology-institute-completes-strategic-refinancing-130000345.html", "source_name": "GlobeNewswire", "published_at": "2026-07-07T13:00:00+00:00", "published_display": "07 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute refinances $86m debt with OrbiMed", "summary": "The Oncology Institute (NASDAQ:TOI) has refinanced its $86 million senior secured convertible note with Deerfield Partners through a new $75 million term loan from OrbiMed and $11 million in cash. This refinancing increases liquidity, improves operating flexibility, and extends d", "url": "https://www.investing.com/news/company-news/oncology-institute-refinances-86m-debt-with-orbimed-93CH-4779406", "source_name": "Investing.com", "published_at": "2026-07-07T13:41:14", "published_display": "07 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Completes Strategic Refinancing with", "summary": "The Oncology Institute (TOI) announced the completion of a strategic refinancing with OrbiMed, repaying an $86 million senior secured convertible note from Deerfield Partners. This new financing arrangement, including a $75 million term loan from OrbiMed, is designed to enhance T", "url": "https://www.globenewswire.com/news-release/2026/07/07/3323245/0/en/the-oncology-institute-completes-strategic-refinancing-with-orbimed-repaying-the-outstanding-86-million-deerfield-convertible-note-strengthening-its-balance-sheet-and-improving-liq.html", "source_name": "GlobeNewswire", "published_at": "2026-07-07T12:41:14", "published_display": "07 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Refinances $86 Million Debt Through OrbiMed Agreement", "summary": "The Oncology Institute (TOI) has completed a strategic agreement with OrbiMed to refinance its outstanding $86 million convertible note previously held by Deerfield. This transaction addresses TOI's existing debt and aims to improve its liquidity and balance sheet structure. The ", "url": "https://www.geneonline.com/the-oncology-institute-refinances-86-million-debt-through-orbimed-agreement/", "source_name": "GeneOnline", "published_at": "2026-07-07T12:41:14", "published_display": "07 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute swaps $86M debt for OrbiMed financing", "summary": "The Oncology Institute (NASDAQ: TOI) has completed a strategic debt refinancing, repaying its $86 million senior secured convertible note with Deerfield Partners. This was achieved through a new $75 million term loan from OrbiMed, set to mature in 2031, plus approximately $11 mil", "url": "https://www.stocktitan.net/news/TOI/the-oncology-institute-completes-strategic-refinancing-with-orbi-med-v8qcn3xgb3qg.html", "source_name": "Stock Titan", "published_at": "2026-07-07T12:41:14", "published_display": "07 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Oncology Institute\u2019s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus", "summary": "The Oncology Institute, Inc. (NASDAQ:TOI) has received analyst upgrades, highlighting confidence in its community-based cancer care growth story. Needham raised its price target to $7 and BTIG to $8, both maintaining Buy ratings. While acknowledging investment risks for TOI, the ", "url": "https://www.insidermonkey.com/blog/why-oncology-institutes-toi-analyst-upgrades-put-its-community-cancer-care-growth-story-in-focus-1797080/?amp=1", "source_name": "Insider Monkey", "published_at": "2026-07-07T03:43:00", "published_display": "07 Jul 2026 03:43", "sentiment": "positive", "sentiment_pct": 78, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street initiates Oncology Institute stock coverage with buy rating By Investing.com", "summary": "Lake Street has initiated coverage on The Oncology Institute Inc. (NASDAQ:TOI) with a Buy rating and a $10.00 price target, citing significant growth in oncology drug spending. The company recently exceeded Q1 2026 earnings expectations, and another firm, Needham, also raised its", "url": "https://ca.investing.com/news/stock-market-news/lake-street-initiates-oncology-institute-stock-coverage-with-buy-rating-93CH-4721102", "source_name": "Investing.com Canada", "published_at": "2026-07-06T14:11:27", "published_display": "06 Jul 2026 14:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "The article focuses on the enterprise value to EBIT forward for The Oncology Institute, Inc., traded under the ticker NASDAQ:TOI. It indicates that the company's financials are available for review on TradingView, a platform providing market data and financial tools. The content ", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T14:11:27", "published_display": "06 Jul 2026 14:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street initiates Oncology Institute stock coverage with buy rating", "summary": "Lake Street has initiated coverage on The Oncology Institute Inc. (NASDAQ:TOI) with a Buy rating and a $10.00 price target, citing significant growth in oral oncolytics spending. The stock has shown strong performance, and analysts maintain a Strong Buy consensus. This comes afte", "url": "https://www.investing.com/news/analyst-ratings/lake-street-initiates-oncology-institute-stock-coverage-with-buy-rating-93CH-4776773", "source_name": "Investing.com", "published_at": "2026-07-06T13:40:54", "published_display": "06 Jul 2026 13:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TOI - Oncology Institute Inc Options", "summary": "This article provides a comprehensive overview of Oncology Institute Inc. (TOI) stock, detailing its financial performance, key ratios, ownership data, and stock performance metrics. It covers important financial figures like market cap, income, sales, and various P/E and EV rati", "url": "https://finviz.com/stock?t=TOI&ta=1&p=m&ty=oc&b=2&r=y5&ov=chain_strike&s=1", "source_name": "Finviz", "published_at": "2026-07-05T09:09:58", "published_display": "05 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Best Medical Care Facilities Stocks to Buy According to Analysts", "summary": "The article identifies The Oncology Institute, Inc. (NASDAQ:TOI) as one of the best medical care facilities stocks to buy, based on analyst recommendations. Analysts project significant upside for TOI, with recent price target increases from Needham and BTIG suggesting confidence", "url": "https://www.insidermonkey.com/blog/5-best-medical-care-facilities-stocks-to-buy-according-to-analysts-1794865/5/", "source_name": "Insider Monkey", "published_at": "2026-07-04T17:22:00", "published_display": "04 Jul 2026 17:22", "sentiment": "positive", "sentiment_pct": 69, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "This article provides financial information for The Oncology Institute, Inc. (NASDAQ: TOI) on TradingView. It specifically highlights the company's \"Price to earnings forward\" metric, displayed within the financial section of its profile. The page indicates that the market is cur", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T23:09:22", "published_display": "02 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "This article provides financial information for The Oncology Institute, Inc. (NASDAQ: TOI). Specifically, it highlights the enterprise value to EBITDA forward metric for the company. The data is presented within a financial platform, likely TradingView, indicating its use for mar", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T03:10:47", "published_display": "02 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "This article provides financial information for The Oncology Institute, Inc. (NASDAQ: TOI), specifically its price-to-sales forward ratio. It notes that the market is closed and there are no trades, indicating a snapshot of a financial metric rather than a news update on recent s", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T02:40:53", "published_display": "01 Jul 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute, Inc.(NasdaqCM:TOI) added to Russell Microcap Value Benchmark Index", "summary": "The Oncology Institute, Inc. (NasdaqCM:TOI) has been included in the Russell Microcap Value Benchmark Index. This announcement follows an earlier update about its inclusion in the Russell 2000 Value Benchmark. The Oncology Institute provides value-based oncology services across 8", "url": "https://www.marketscreener.com/news/the-oncology-institute-inc-nasdaqcm-toi-added-to-russell-microcap-value-benchmark-index-ce7f5fdfdb8bfe26", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T16:12:27", "published_display": "29 Jun 2026 16:12", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?", "summary": "The Oncology Institute (TOI) shares recently gained 5.3%, contributing to an 8.7% rise over the past four weeks, with high trading volume. The company is expected to report a quarterly loss of $0.07 per share, an improvement of 50% year-over-year, and revenues of $156.15 million,", "url": "https://sg.finance.yahoo.com/news/oncology-institute-toi-soars-5-143000105.html", "source_name": "Market source", "published_at": "2026-06-29T14:12:27", "published_display": "29 Jun 2026 14:12", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) major holder Jorey Chernett buys 18,000 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOSGNWeExhdTd6eHQ1UVdlTEJsSk1lMmt6UE45dWdhZUpoUGdoa2ZCeVhWVEdmZld2SjNDVlB1RmdPWjFReHhpZkxtMHFITHN1UmN4VHF1bFpPMWl1WWw4ZUZOMmhMUXVZeUlrSzZmOXJzc09vTER5WW05Z2c3b2diaTUxdWdKZVdVUkc0MlhkZXM1ek9sR19ldUFBSlA2YS1HenBESkI2M0lWbE1SZTNJM1BpVHdvZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology institute ten percent owner Jorey Chernett buys $90k in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOaUlQZFM3UHJjZDVLWE5iOHlYSnlhTWdldnE5NGVLYjZ0SnZhbzNfSWdHVy1hRzVDTDU0RjlyUFk2WTdzMk5TSVhnNWJXQ3ZNa0pwWUFhV2Q1NVNpcjJZX21EQm5rNnRoYVZQZnlKZXRkRW9XYmxwWjZialhZWmlvNUFzcDl0TXh0RUNLcjloOVE1eExDa1Z6ZXJuWTVKTXlBYUdfMXd0S0pWZDA3TE0xcU5ZWnlxZXhVRTVpQWE5STQyeFJpNmNBMEt3?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNUXpHUzM4LWZWbUlCa29Vb3g5RU95WThyR09oUXY5UVF0T1RWUFM5TEFHbDV4dFFZSkRTcVRMUWlBemNJc1FKS180Tkd1WENKT3JTRThuUmQtR1hnYjdDRTlwNS1ucjF5VTlldjd3R00zMUlYLUhMd0taRFIyYkhvMnJ5bG1mV2Vpd1l0Mm9FeEpzREljNDY4VDEwU0gzaEk0U0E?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/oncology-institute-chief-medical-officer-130000975.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T13:00:00+00:00", "published_display": "26 May 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider boosts Oncology Institute (TOI) stake with 38,500-share open-market buys", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQcGQ1TkhuOVk3Z3IweVk0SVV3ZzQxcmVLR3NNN1A5OW1Dc3lRY3B5eGxzRUVVaHJrMU1NVjNFMjlaZEp4WWVZOTZ4U2drYm5qMlpRS0lnREtpTGx1N3YtQml5dXNKZDU1U2NhdTZXNkpvOHlDbGgwU1lEMHBpMzJPbXduMDZVN0s5UEFYUnc4NUNNUVM5czZwN2dYMWhJLU95T3pyeFpfY09MUmFpa3BQYkZ1SDJ6QQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jorey Chernett buys $156,595 of Oncology Institute stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQcWhrdUpMRmJOWk9NVUVXLWRXYmtwYVhMd1c2YUtFMml3MzRHNnBPM1RmTnhoWVVNUVN0bUY3S1FQdEhzZzVVbV80TmhheWpXdmNzWHhrbkdvRElqbzlHRkFoelRDdWpvdTVXSmdzV2lSM3RHaUpNcGZ4U3lpNHhDVjRmZk9HRUpBOGpSeGFMRjhYM0JNTmVBNmdCeEI1OWY2UGpEV3dvR2d2bnBhWHI0SVpSM0dFeXNzQlZZ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference", "summary": "", "url": "https://finance.yahoo.com/news/oncology-institute-participate-b-riley-130000300.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T13:00:00+00:00", "published_display": "13 May 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute, Inc. (NASDAQ:TOI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOZnNRU3FKSGhyNEJacHd2NGhRVWttRTR4emhJT3FJOWdQSVRacXVOWFdCeWtnTXctMEdHSFd1Q0dRMDdxRkdnM3M1aXlkZy11Y0l0RWN6dEV4NkR4V29XZVo0NkNlbXpZUVJGc3BGdUoxTXJ5SUpVT3RMM1dIMl9TQWwyWmxtSmc5NTFUYnNodEtrblBaNnJ2VFRVTzd3UTg?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute Q1 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOZFppNkxfazYxcDZwczRUU1lWOXNQUmd6LU05azhTMHJUVWRHQjJOUjl5dTkxRk44aGcyR05PYmtldUdMYWtnTHFQNnNuWUMxNkhXcFR5V3hBQUwwZ0kzbUhOeVJ6RU96YW9Vak5rZkVCNVcxOFl5dEpGVDYxd1ZpcXVpenljM1dXSmROY194WjNkakI0TTVycnU4amZYcENBVGhzenZySkF5eGhLTTJzdGY3clMycjN3aXA1NmphWGlrUFZ2RDB6Vzl3?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPNURQQmJhTE55dDZPZm5ucUJCNDJMV0lJQll0RlpSaXYyT1lGTXRfVldLRXY3OXY0b0VCZi1KTl9zVFFjdWs3MW1yTTVrZWY4aVY5NXJrcUlVNlpKc2h1bko4eHlBVDZ1WjhDRGVTakFXSndVQmFMaFN1d1RPN0xwUWZZNU9XM3FOcm1mcFBEOEc2SjhFM09nenBpN0s1WFhYQmlJVUtiQmdGemoxTG04WEc1V1dGYW0tVmIxX0N6TFFtS3d3RnNNZ0lLV3hIbW1mTVNwQ2hB?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Inc. (TOI) stock rises on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNdXlfRDlCbXlEVTcwQXo1WTZfVjNWN09LUmYwRW92RzI1VXhrdXFpemtWZlpIVm1qLUFoNENndGpQOUlzNkZLc2M0OE9GNDBjMVlQUUZsa0FOZU9maEVhUkp2eTZYTnQxUURZM210SWdQREwwTUdxdVdUek1pUHJDQUZaQnNPT1JtQXZUNW1nYUIxbEV0NHpvbUhGSXlpTFRESkFJWg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s What Powered The Oncology Institute\u2019s (TOI) Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNdTdBTjFTWmxuMkIwbWNwZTBwSzFCRnYxZG1kSFotMEVaTTl5YmlIbGZOSWhfWEpPbjVZMGNDcFJGMHQ0anhqTFF6akxRREtCdngzSldaT0Z2OEdUUmp5SjRPelRzb3lDTS00MmkwSWNsR2FVdjE2TWpMRUF6TER4WFUyLWhnZFhRMlE3QUZEVjN2OHl3TU9FU1A2M2FJNGhMcE9J?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chernett Jorey buys Oncology Institute (TOI) shares worth $157,500", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTE5URTRtdG1FV19sc21WSVJOVGlZYkVfUVctRDdLTjBxcm9fbHpuOHNJUkRyZExXR1FHaHFkaHFXbVNfV2hPeVlQZGpqMVZFUWs5T0h3TnoyU3o1V2tlQU9PZjZTT2hRbHVhR011cmFuamxPeF9JNi1SdWVQWUFiSFZBci1PSlBYeVkzaUxHcTdhZ2lVdDY3YVVOU0UxT09KcUl5S2J2dVFsMHlfWkxwQi1ZeEp2blRLZ0Z5bnAwNW5HN1FTS2c?oc=5", "source_name": "Investing.com", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) CMO logs RSU tax-cover share sale on Form 4", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQTmh0ak01VnVPNS1qZ0dkNjBNNVE3Zl9CV2pPSEZobFdmbFZRT3RyZjhSOXFDUDB6UlFBa0VEblV4ZzJ2Z3NHeVN3OS1CQjR3ZDN1czd1OHNLTWNhV1FNT29uX2NmZG85SG9ULU5GVjZsMG54RW9ITmVfaDcwSS1fQnowSkhEYmFXSUNUZjlLLXZHTnFhTVRxdkl0ZkpqYTA3X18xbTQ2X01ielIzRk5VMW45NkxOdWM?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQSnRKOXltVTl0VnJmTkR5QTlqTndnOU9Pb21pbGhOb2h6UnZROEVjTmtoN3I4aGdFdjdBS3FfMXZVa1dWR2NsaFI4RV9yVTNwV25jWUlncXZpUEV3TDl1Zm9talk3TDNMMk41ZDhKajJtOG10dDFkUnowb3dhRmNKdXhOdUZiQ1RPSFRyNGtGZnE?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Give The Oncology Institute, Inc. (NASDAQ:TOI) Shares A 26% Hiding", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Oncology Institute\u2019s (TOI) New Tech\u2011Heavy Leadership Team Quietly Reframing Its Value\u2011Based Care Ambitions?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Oncology Institute (TOI) Valuation After Mark Stolper Joins The Board", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "For Oncology Institute Insiders, Selling US$644k Of Shares Was A Smart Move", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute: Making Progress (NASDAQ:TOI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQbjJSaWdYN2xrbWRMckt2NzNrWmQyU283Q1NmOXdRY1hUU0lBdnF6dWMzTFhwbHR0RjQtb3UxVHl0OEpGWWJJcXlvcjBqUjdFa3dMa1lKenpuWVJmOGZaQVNpYjMwMzBGRXFOVUtabUprRXB3U0swNkNHLU96LUlpdlQzcHp3Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Both individual investors who control a good portion of The Oncology Institute, Inc. (NASDAQ:TOI) along with institutions must be dismayed after last week's 13% decrease", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "TOI (NASDAQ: TOI) plans sale of 23,452 shares worth $146,575.00", "summary": "The Oncology Institute, Inc. (NASDAQ: TOI) has filed a Form 144 notice indicating a planned sale of 23,452 shares of common stock, valued at $146,575.00, through Morgan Stanley Smith Barney LLC Executive Financial Services. These shares were acquired on July 14, 2026, via an exer", "url": "https://www.stocktitan.net/sec-filings/TOI/144-oncology-institute-inc-sec-filing-6906e01b8853.html", "source_name": "Stock Titan", "published_at": "2026-07-14T20:41:59", "published_display": "14 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 The Oncology Institute For: 14 July By Investing.com", "summary": "This article announces a Form 144 filing for The Oncology Institute, specifically for July 14th. The content is very brief, mainly serving as a headline for a financial market filing, with no further details provided within the article itself. It includes related stock market dat", "url": "https://ca.investing.com/news/stock-market-news/form-144-the-oncology-institute-for-14-july-93CH-4733933", "source_name": "Investing.com Canada", "published_at": "2026-07-14T20:41:59", "published_display": "14 Jul 2026 20:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Buying: Jorey Chernett Acquires Additional Shares of The Oncology Institute Inc (TOI)", "summary": "Jorey Chernett, a 10% Owner of The Oncology Institute Inc (TOI), purchased an additional 15,000 shares on July 10, 2026, increasing his total holdings to 10,630,858 shares. This purchase is part of a broader trend of insider buying for TOI, with Chernett having acquired 759,914 s", "url": "https://www.gurufocus.com/news/8955984/insider-buying-jorey-chernett-acquires-additional-shares-of-the-oncology-institute-inc-toi", "source_name": "GuruFocus", "published_at": "2026-07-13T18:40:52", "published_display": "13 Jul 2026 18:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) major holder buys 15,000 shares in open market", "summary": "Jorey Chernett, a major shareholder (over 10% owner) of Oncology Institute, Inc. (TOI), purchased 15,000 shares of common stock on July 10, 2026, for a weighted average price of $5.85 per share. This open-market transaction, detailed in a Form 4 filing, involved multiple trades w", "url": "https://www.stocktitan.net/sec-filings/TOI/form-4-oncology-institute-inc-insider-trading-activity-4a8cb138f084.html", "source_name": "Stock Titan", "published_at": "2026-07-13T15:39:35", "published_display": "13 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Oncology Institute Inc For: 13 July By Investing.com", "summary": "This article from Investing.com announces the filing of a Form 4 for Oncology Institute Inc on July 13. It includes general market data and related news articles, but provides no specific details about the Form 4 itself.", "url": "https://ca.investing.com/news/stock-market-news/form-4-oncology-institute-inc-for-13-july-93CH-4731571", "source_name": "Investing.com Canada", "published_at": "2026-07-13T15:39:35", "published_display": "13 Jul 2026 15:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute (TOI) Proxy filing Summary", "summary": "The Oncology Institute (TOI) has released a proxy filing summary detailing its upcoming annual meeting scheduled for June 17, 2026. Key items include the election of eight directors, the ratification of BDO as the independent public accounting firm for 2026, and advisory votes on", "url": "https://quartr.com/events/the-oncology-institute-toi-proxy-filing_onCTCXdr", "source_name": "Quartr", "published_at": "2026-07-10T11:10:04", "published_display": "10 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TOIIW SEC Filings - The Oncology Institute Inc 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for SEC filings related to The Oncology Institute Inc. (TOIIW), including 10-K, 10-Q, 8-K, and insider trading forms. Recent updates detail insider transactions by director Gabriel Ling, his resignation from the board, and a significant", "url": "https://www.stocktitan.net/sec-filings/TOIIW/page-5.html", "source_name": "Stock Titan", "published_at": "2026-07-10T09:09:37", "published_display": "10 Jul 2026 09:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) Short Interest & Short Float | Updated Jul 2026 $TOI", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE1ISmJtZlMxVkRNRm9XSWFsNDRIUGZncEhEVTNFdlIxTkphb3JPNl9laUVEU0ZJLWRRTVotMkRXZnJtb2k1a2tJQmdwT3dsVURaRHlQUEdISEZKTkdCTnEwTGp4MlBGTTFEQ3Q4Sg?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-10T07:00:00+00:00", "published_display": "10 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute Price Target Raised to $9.00/Share From $8.00 by BTIG", "summary": "BTIG has increased its price target for The Oncology Institute to $9.00 per share, up from the previous $8.00. This adjustment by BTIG analysts suggests a more optimistic outlook for the company's stock performance. The Oncology Institute is traded on the NASDAQ under the ticker ", "url": "https://www.moomoo.com/news/post/72730789/oncology-institute-price-target-raised-to-9-00-share-from", "source_name": "Moomoo", "published_at": "2026-07-10T00:10:04", "published_display": "10 Jul 2026 00:10", "sentiment": "positive", "sentiment_pct": 69, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG Maintains The Oncology Institute(TOI.US) With Buy Rating, Raises Target Price to $9", "summary": "BTIG has reiterated its Buy rating on The Oncology Institute (TOI.US) and increased its target price to $9. This indicates a positive outlook from the analyst firm regarding the company's future stock performance.", "url": "https://www.moomoo.com/news/post/72730109/btig-maintains-the-oncology-institute-toius-with-buy-rating-raises", "source_name": "Moomoo", "published_at": "2026-07-09T23:41:59", "published_display": "09 Jul 2026 23:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BTIG raises Oncology Institute stock price target to $9 on debt refinancing", "summary": "BTIG has increased its price target for The Oncology Institute (NASDAQ:TOI) to $9.00 from $8.00, maintaining a Buy rating after the company announced it refinanced its $86 million senior secured convertible note. The refinancing involved a new $75 million term loan from OrbiMed a", "url": "https://www.investing.com/news/analyst-ratings/btig-raises-oncology-institute-stock-price-target-to-9-on-debt-refinancing-93CH-4784657", "source_name": "Investing.com", "published_at": "2026-07-09T22:10:04", "published_display": "09 Jul 2026 22:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) director receives 17,185-share fully vested RSU grant", "summary": "Oncology Institute (TOI) director Kimberly Jo Tzoumakas received a fully vested Restricted Stock Unit (RSU) grant of 17,185 shares of common stock on July 7, 2026, as reported in a Form 4 SEC filing. The grant was recorded at a price of $0.00 per share and is considered compensat", "url": "https://www.stocktitan.net/sec-filings/TOI/form-4-oncology-institute-inc-insider-trading-activity-2c1093db91d0.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:59:19", "published_display": "09 Jul 2026 20:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) director receives 25,833 fully vested RSU shares", "summary": "Oncology Institute (TOI) director Mark Stolper reported receiving 25,833 fully vested Restricted Stock Units (RSU) shares of common stock on July 7, 2026, as an equity compensation grant. This transaction, classified as a non-cash award at $0.00 per share, increases Stolper's dir", "url": "https://www.stocktitan.net/sec-filings/TOI/form-4-oncology-institute-inc-insider-trading-activity-8738f43a0a78.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:59:18", "published_display": "09 Jul 2026 20:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street Initiates The Oncology Institute(TOI.US) With Buy Rating, Announces Target Price $10", "summary": "Lake Street has initiated coverage on The Oncology Institute (TOI.US) with a \"Buy\" rating and set a price target of $10. This signals a positive outlook from the analyst firm regarding the company's future performance.", "url": "https://www.moomoo.com/news/post/72524018/lake-street-initiates-the-oncology-institute-toius-with-buy-rating", "source_name": "Moomoo", "published_at": "2026-07-07T22:10:05", "published_display": "07 Jul 2026 22:10", "sentiment": "positive", "sentiment_pct": 74, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (NASDAQ: TOI) adds $75M OrbiMed loan in major refi", "summary": "The Oncology Institute (NASDAQ: TOI) has completed a major refinancing deal, securing a new $75 million term loan from OrbiMed Opportunities. This new loan, maturing in 2031, was used along with $11 million in cash to repay their existing $86 million 4% senior secured convertible", "url": "https://www.stocktitan.net/sec-filings/TOI/8-k-oncology-institute-inc-reports-material-event-61d126af9287.html", "source_name": "Stock Titan", "published_at": "2026-07-07T21:01:14", "published_display": "07 Jul 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "This article provides the enterprise value to forward revenue for The Oncology Institute, Inc., traded on NASDAQ under the ticker TOI. It is presented in the context of financial data available on TradingView, covering market information and financial performance indicators for t", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-07T14:41:14", "published_display": "07 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/oncology-institute-completes-strategic-refinancing-130000345.html", "source_name": "GlobeNewswire", "published_at": "2026-07-07T13:00:00+00:00", "published_display": "07 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute refinances $86m debt with OrbiMed", "summary": "The Oncology Institute (NASDAQ:TOI) has refinanced its $86 million senior secured convertible note with Deerfield Partners through a new $75 million term loan from OrbiMed and $11 million in cash. This refinancing increases liquidity, improves operating flexibility, and extends d", "url": "https://www.investing.com/news/company-news/oncology-institute-refinances-86m-debt-with-orbimed-93CH-4779406", "source_name": "Investing.com", "published_at": "2026-07-07T13:41:14", "published_display": "07 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Completes Strategic Refinancing with", "summary": "The Oncology Institute (TOI) announced the completion of a strategic refinancing with OrbiMed, repaying an $86 million senior secured convertible note from Deerfield Partners. This new financing arrangement, including a $75 million term loan from OrbiMed, is designed to enhance T", "url": "https://www.globenewswire.com/news-release/2026/07/07/3323245/0/en/the-oncology-institute-completes-strategic-refinancing-with-orbimed-repaying-the-outstanding-86-million-deerfield-convertible-note-strengthening-its-balance-sheet-and-improving-liq.html", "source_name": "GlobeNewswire", "published_at": "2026-07-07T12:41:14", "published_display": "07 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 76, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Refinances $86 Million Debt Through OrbiMed Agreement", "summary": "The Oncology Institute (TOI) has completed a strategic agreement with OrbiMed to refinance its outstanding $86 million convertible note previously held by Deerfield. This transaction addresses TOI's existing debt and aims to improve its liquidity and balance sheet structure. The ", "url": "https://www.geneonline.com/the-oncology-institute-refinances-86-million-debt-through-orbimed-agreement/", "source_name": "GeneOnline", "published_at": "2026-07-07T12:41:14", "published_display": "07 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute swaps $86M debt for OrbiMed financing", "summary": "The Oncology Institute (NASDAQ: TOI) has completed a strategic debt refinancing, repaying its $86 million senior secured convertible note with Deerfield Partners. This was achieved through a new $75 million term loan from OrbiMed, set to mature in 2031, plus approximately $11 mil", "url": "https://www.stocktitan.net/news/TOI/the-oncology-institute-completes-strategic-refinancing-with-orbi-med-v8qcn3xgb3qg.html", "source_name": "Stock Titan", "published_at": "2026-07-07T12:41:14", "published_display": "07 Jul 2026 12:41", "sentiment": "positive", "sentiment_pct": 71, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Oncology Institute\u2019s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus", "summary": "The Oncology Institute, Inc. (NASDAQ:TOI) has received analyst upgrades, highlighting confidence in its community-based cancer care growth story. Needham raised its price target to $7 and BTIG to $8, both maintaining Buy ratings. While acknowledging investment risks for TOI, the ", "url": "https://www.insidermonkey.com/blog/why-oncology-institutes-toi-analyst-upgrades-put-its-community-cancer-care-growth-story-in-focus-1797080/?amp=1", "source_name": "Insider Monkey", "published_at": "2026-07-07T03:43:00", "published_display": "07 Jul 2026 03:43", "sentiment": "positive", "sentiment_pct": 78, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street initiates Oncology Institute stock coverage with buy rating By Investing.com", "summary": "Lake Street has initiated coverage on The Oncology Institute Inc. (NASDAQ:TOI) with a Buy rating and a $10.00 price target, citing significant growth in oncology drug spending. The company recently exceeded Q1 2026 earnings expectations, and another firm, Needham, also raised its", "url": "https://ca.investing.com/news/stock-market-news/lake-street-initiates-oncology-institute-stock-coverage-with-buy-rating-93CH-4721102", "source_name": "Investing.com Canada", "published_at": "2026-07-06T14:11:27", "published_display": "06 Jul 2026 14:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "The article focuses on the enterprise value to EBIT forward for The Oncology Institute, Inc., traded under the ticker NASDAQ:TOI. It indicates that the company's financials are available for review on TradingView, a platform providing market data and financial tools. The content ", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T14:11:27", "published_display": "06 Jul 2026 14:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lake Street initiates Oncology Institute stock coverage with buy rating", "summary": "Lake Street has initiated coverage on The Oncology Institute Inc. (NASDAQ:TOI) with a Buy rating and a $10.00 price target, citing significant growth in oral oncolytics spending. The stock has shown strong performance, and analysts maintain a Strong Buy consensus. This comes afte", "url": "https://www.investing.com/news/analyst-ratings/lake-street-initiates-oncology-institute-stock-coverage-with-buy-rating-93CH-4776773", "source_name": "Investing.com", "published_at": "2026-07-06T13:40:54", "published_display": "06 Jul 2026 13:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TOI - Oncology Institute Inc Options", "summary": "This article provides a comprehensive overview of Oncology Institute Inc. (TOI) stock, detailing its financial performance, key ratios, ownership data, and stock performance metrics. It covers important financial figures like market cap, income, sales, and various P/E and EV rati", "url": "https://finviz.com/stock?t=TOI&ta=1&p=m&ty=oc&b=2&r=y5&ov=chain_strike&s=1", "source_name": "Finviz", "published_at": "2026-07-05T09:09:58", "published_display": "05 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Best Medical Care Facilities Stocks to Buy According to Analysts", "summary": "The article identifies The Oncology Institute, Inc. (NASDAQ:TOI) as one of the best medical care facilities stocks to buy, based on analyst recommendations. Analysts project significant upside for TOI, with recent price target increases from Needham and BTIG suggesting confidence", "url": "https://www.insidermonkey.com/blog/5-best-medical-care-facilities-stocks-to-buy-according-to-analysts-1794865/5/", "source_name": "Insider Monkey", "published_at": "2026-07-04T17:22:00", "published_display": "04 Jul 2026 17:22", "sentiment": "positive", "sentiment_pct": 69, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "This article provides financial information for The Oncology Institute, Inc. (NASDAQ: TOI) on TradingView. It specifically highlights the company's \"Price to earnings forward\" metric, displayed within the financial section of its profile. The page indicates that the market is cur", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T23:09:22", "published_display": "02 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "This article provides financial information for The Oncology Institute, Inc. (NASDAQ: TOI). Specifically, it highlights the enterprise value to EBITDA forward metric for the company. The data is presented within a financial platform, likely TradingView, indicating its use for mar", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-07-02T03:10:47", "published_display": "02 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of The Oncology Institute, Inc. \u2013 NASDAQ:TOI", "summary": "This article provides financial information for The Oncology Institute, Inc. (NASDAQ: TOI), specifically its price-to-sales forward ratio. It notes that the market is closed and there are no trades, indicating a snapshot of a financial metric rather than a news update on recent s", "url": "https://www.tradingview.com/symbols/NASDAQ-TOI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-01T02:40:53", "published_display": "01 Jul 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute, Inc.(NasdaqCM:TOI) added to Russell Microcap Value Benchmark Index", "summary": "The Oncology Institute, Inc. (NasdaqCM:TOI) has been included in the Russell Microcap Value Benchmark Index. This announcement follows an earlier update about its inclusion in the Russell 2000 Value Benchmark. The Oncology Institute provides value-based oncology services across 8", "url": "https://www.marketscreener.com/news/the-oncology-institute-inc-nasdaqcm-toi-added-to-russell-microcap-value-benchmark-index-ce7f5fdfdb8bfe26", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T16:12:27", "published_display": "29 Jun 2026 16:12", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?", "summary": "The Oncology Institute (TOI) shares recently gained 5.3%, contributing to an 8.7% rise over the past four weeks, with high trading volume. The company is expected to report a quarterly loss of $0.07 per share, an improvement of 50% year-over-year, and revenues of $156.15 million,", "url": "https://sg.finance.yahoo.com/news/oncology-institute-toi-soars-5-143000105.html", "source_name": "Market source", "published_at": "2026-06-29T14:12:27", "published_display": "29 Jun 2026 14:12", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) major holder Jorey Chernett buys 18,000 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOSGNWeExhdTd6eHQ1UVdlTEJsSk1lMmt6UE45dWdhZUpoUGdoa2ZCeVhWVEdmZld2SjNDVlB1RmdPWjFReHhpZkxtMHFITHN1UmN4VHF1bFpPMWl1WWw4ZUZOMmhMUXVZeUlrSzZmOXJzc09vTER5WW05Z2c3b2diaTUxdWdKZVdVUkc0MlhkZXM1ek9sR19ldUFBSlA2YS1HenBESkI2M0lWbE1SZTNJM1BpVHdvZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology institute ten percent owner Jorey Chernett buys $90k in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOaUlQZFM3UHJjZDVLWE5iOHlYSnlhTWdldnE5NGVLYjZ0SnZhbzNfSWdHVy1hRzVDTDU0RjlyUFk2WTdzMk5TSVhnNWJXQ3ZNa0pwWUFhV2Q1NVNpcjJZX21EQm5rNnRoYVZQZnlKZXRkRW9XYmxwWjZialhZWmlvNUFzcDl0TXh0RUNLcjloOVE1eExDa1Z6ZXJuWTVKTXlBYUdfMXd0S0pWZDA3TE0xcU5ZWnlxZXhVRTVpQWE5STQyeFJpNmNBMEt3?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNUXpHUzM4LWZWbUlCa29Vb3g5RU95WThyR09oUXY5UVF0T1RWUFM5TEFHbDV4dFFZSkRTcVRMUWlBemNJc1FKS180Tkd1WENKT3JTRThuUmQtR1hnYjdDRTlwNS1ucjF5VTlldjd3R00zMUlYLUhMd0taRFIyYkhvMnJ5bG1mV2Vpd1l0Mm9FeEpzREljNDY4VDEwU0gzaEk0U0E?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/oncology-institute-chief-medical-officer-130000975.html", "source_name": "GlobeNewswire", "published_at": "2026-05-26T13:00:00+00:00", "published_display": "26 May 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider boosts Oncology Institute (TOI) stake with 38,500-share open-market buys", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQcGQ1TkhuOVk3Z3IweVk0SVV3ZzQxcmVLR3NNN1A5OW1Dc3lRY3B5eGxzRUVVaHJrMU1NVjNFMjlaZEp4WWVZOTZ4U2drYm5qMlpRS0lnREtpTGx1N3YtQml5dXNKZDU1U2NhdTZXNkpvOHlDbGgwU1lEMHBpMzJPbXduMDZVN0s5UEFYUnc4NUNNUVM5czZwN2dYMWhJLU95T3pyeFpfY09MUmFpa3BQYkZ1SDJ6QQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jorey Chernett buys $156,595 of Oncology Institute stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQcWhrdUpMRmJOWk9NVUVXLWRXYmtwYVhMd1c2YUtFMml3MzRHNnBPM1RmTnhoWVVNUVN0bUY3S1FQdEhzZzVVbV80TmhheWpXdmNzWHhrbkdvRElqbzlHRkFoelRDdWpvdTVXSmdzV2lSM3RHaUpNcGZ4U3lpNHhDVjRmZk9HRUpBOGpSeGFMRjhYM0JNTmVBNmdCeEI1OWY2UGpEV3dvR2d2bnBhWHI0SVpSM0dFeXNzQlZZ?oc=5", "source_name": "Investing.com", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference", "summary": "", "url": "https://finance.yahoo.com/news/oncology-institute-participate-b-riley-130000300.html", "source_name": "GlobeNewswire", "published_at": "2026-05-13T13:00:00+00:00", "published_display": "13 May 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute, Inc. (NASDAQ:TOI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOZnNRU3FKSGhyNEJacHd2NGhRVWttRTR4emhJT3FJOWdQSVRacXVOWFdCeWtnTXctMEdHSFd1Q0dRMDdxRkdnM3M1aXlkZy11Y0l0RWN6dEV4NkR4V29XZVo0NkNlbXpZUVJGc3BGdUoxTXJ5SUpVT3RMM1dIMl9TQWwyWmxtSmc5NTFUYnNodEtrblBaNnJ2VFRVTzd3UTg?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute Q1 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOZFppNkxfazYxcDZwczRUU1lWOXNQUmd6LU05azhTMHJUVWRHQjJOUjl5dTkxRk44aGcyR05PYmtldUdMYWtnTHFQNnNuWUMxNkhXcFR5V3hBQUwwZ0kzbUhOeVJ6RU96YW9Vak5rZkVCNVcxOFl5dEpGVDYxd1ZpcXVpenljM1dXSmROY194WjNkakI0TTVycnU4amZYcENBVGhzenZySkF5eGhLTTJzdGY3clMycjN3aXA1NmphWGlrUFZ2RDB6Vzl3?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPNURQQmJhTE55dDZPZm5ucUJCNDJMV0lJQll0RlpSaXYyT1lGTXRfVldLRXY3OXY0b0VCZi1KTl9zVFFjdWs3MW1yTTVrZWY4aVY5NXJrcUlVNlpKc2h1bko4eHlBVDZ1WjhDRGVTakFXSndVQmFMaFN1d1RPN0xwUWZZNU9XM3FOcm1mcFBEOEc2SjhFM09nenBpN0s1WFhYQmlJVUtiQmdGemoxTG04WEc1V1dGYW0tVmIxX0N6TFFtS3d3RnNNZ0lLV3hIbW1mTVNwQ2hB?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Inc. (TOI) stock rises on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNdXlfRDlCbXlEVTcwQXo1WTZfVjNWN09LUmYwRW92RzI1VXhrdXFpemtWZlpIVm1qLUFoNENndGpQOUlzNkZLc2M0OE9GNDBjMVlQUUZsa0FOZU9maEVhUkp2eTZYTnQxUURZM210SWdQREwwTUdxdVdUek1pUHJDQUZaQnNPT1JtQXZUNW1nYUIxbEV0NHpvbUhGSXlpTFRESkFJWg?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here\u2019s What Powered The Oncology Institute\u2019s (TOI) Gains", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNdTdBTjFTWmxuMkIwbWNwZTBwSzFCRnYxZG1kSFotMEVaTTl5YmlIbGZOSWhfWEpPbjVZMGNDcFJGMHQ0anhqTFF6akxRREtCdngzSldaT0Z2OEdUUmp5SjRPelRzb3lDTS00MmkwSWNsR2FVdjE2TWpMRUF6TER4WFUyLWhnZFhRMlE3QUZEVjN2OHl3TU9FU1A2M2FJNGhMcE9J?oc=5", "source_name": "Market source", "published_at": "2026-04-20T07:00:00+00:00", "published_display": "20 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chernett Jorey buys Oncology Institute (TOI) shares worth $157,500", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQTE5URTRtdG1FV19sc21WSVJOVGlZYkVfUVctRDdLTjBxcm9fbHpuOHNJUkRyZExXR1FHaHFkaHFXbVNfV2hPeVlQZGpqMVZFUWs5T0h3TnoyU3o1V2tlQU9PZjZTT2hRbHVhR011cmFuamxPeF9JNi1SdWVQWUFiSFZBci1PSlBYeVkzaUxHcTdhZ2lVdDY3YVVOU0UxT09KcUl5S2J2dVFsMHlfWkxwQi1ZeEp2blRLZ0Z5bnAwNW5HN1FTS2c?oc=5", "source_name": "Investing.com", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oncology Institute (TOI) CMO logs RSU tax-cover share sale on Form 4", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQTmh0ak01VnVPNS1qZ0dkNjBNNVE3Zl9CV2pPSEZobFdmbFZRT3RyZjhSOXFDUDB6UlFBa0VEblV4ZzJ2Z3NHeVN3OS1CQjR3ZDN1czd1OHNLTWNhV1FNT29uX2NmZG85SG9ULU5GVjZsMG54RW9ITmVfaDcwSS1fQnowSkhEYmFXSUNUZjlLLXZHTnFhTVRxdkl0ZkpqYTA3X18xbTQ2X01ielIzRk5VMW45NkxOdWM?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxQSnRKOXltVTl0VnJmTkR5QTlqTndnOU9Pb21pbGhOb2h6UnZROEVjTmtoN3I4aGdFdjdBS3FfMXZVa1dWR2NsaFI4RV9yVTNwV25jWUlncXZpUEV3TDl1Zm9talk3TDNMMk41ZDhKajJtOG10dDFkUnowb3dhRmNKdXhOdUZiQ1RPSFRyNGtGZnE?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investors Give The Oncology Institute, Inc. (NASDAQ:TOI) Shares A 26% Hiding", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-02T08:00:00+00:00", "published_display": "02 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Oncology Institute\u2019s (TOI) New Tech\u2011Heavy Leadership Team Quietly Reframing Its Value\u2011Based Care Ambitions?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Oncology Institute (TOI) Valuation After Mark Stolper Joins The Board", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-09T08:00:00+00:00", "published_display": "09 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "For Oncology Institute Insiders, Selling US$644k Of Shares Was A Smart Move", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNWlNfTGx3enpTYXJDRi1CT01QWjlXY25VZ0x4SjRkUV85YzE1bkF5TUJkelV2RmVhckRkR1dVUkNXTlViUE4yUERrX01SelZmY3paTjV0QS02VV9kUlkycUZQOWJWMWsxRUtRNG9xT2Z6VzlTMkFHaHVxenU5aHZZMmU5SGRxQ0ZFRVRRMzVnUE5LY1pQcFR1SjlQWTluVEZ5WXYwbXMwbF9felR4WjltTDluQjhzdXZ1MHRJM2lCZ1lWNHpudEJsMjNWSTlnb2JFQ01vONIB2gFBVV95cUxORUV5RVoxSXVfcktWZUJldXZMQWpQS3VBa2MzNXhUVFBVMjlfTUEySWlXMTFaQi1jajItc2U0VnlOQ0xNUzhJbWNkVTlKN0VUV095UHRfaWVFWmJxUWJYMHFseWFxdVJnRFJrWWFZMDBhMDNnMzlndm5KRDhDbm9wNlVoeDJVWFh6UDJCb3ZZVU51YXhaaDJsZURBanF4M3EwZWpsSnNQSVBsQXN1SktGZXFCSVZrYTEzbDNXTVBrVS00TDRRNTBMOGMyaUVockF1dmZURUdFU1dZdw?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-07T08:00:00+00:00", "published_display": "07 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Oncology Institute: Making Progress (NASDAQ:TOI)", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQbjJSaWdYN2xrbWRMckt2NzNrWmQyU283Q1NmOXdRY1hUU0lBdnF6dWMzTFhwbHR0RjQtb3UxVHl0OEpGWWJJcXlvcjBqUjdFa3dMa1lKenpuWVJmOGZaQVNpYjMwMzBGRXFOVUtabUprRXB3U0swNkNHLU96LUlpdlQzcHp3Zw?oc=5", "source_name": "Seeking Alpha", "published_at": "2025-12-18T08:00:00+00:00", "published_display": "18 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Both individual investors who control a good portion of The Oncology Institute, Inc. (NASDAQ:TOI) along with institutions must be dismayed after last week's 13% decrease", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-06T08:00:00+00:00", "published_display": "06 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 96, "total_relevant": 54, "sentiment_summary": {"positive": 19, "negative": 1, "neutral": 34, "score": 58, "total": 54, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 17.4, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 8}, {"event": "analyst", "label": "Analyst action", "weight": 3.85, "count": 7}, {"event": "liquidity", "label": "Balance sheet", "weight": 3.85, "count": 7}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 19, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 5.89, "latest_week": "2026-07-10", "one_week_move": 11.6, "four_week_move": 10.9, "twelve_week_move": 66.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.632338, "market_dynamics_buy_signal": false, "relative_strength": 36.948867, "fair_value_gap": 186.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 53.6518, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+11.6% over one week, +10.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 68, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 10}, {"label": "simplywall.st", "count": 6}, {"label": "Investing.com", "count": 5}, {"label": "TradingView", "count": 5}, {"label": "GlobeNewswire", "count": 5}, {"label": "Market source", "count": 5}, {"label": "Investing.com Canada", "count": 4}, {"label": "Moomoo", "count": 3}], "tiers": [{"label": "Direct company coverage", "count": 54}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 8}, {"label": "Analyst action", "count": 7}, {"label": "Balance sheet", "count": 7}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "54", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+11.6% over one week, +10.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "TOI (NASDAQ: TOI) plans sale of 23,452 shares worth $146,575.00"}], "updated_at": "2026-07-15T23:13:30.795174+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}